| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
26,921 |
21,097 |
$291K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,938 |
1,557 |
$140K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,425 |
6,799 |
$92K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,917 |
9,822 |
$77K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,993 |
2,393 |
$69K |
| 80053 |
Comprehensive metabolic panel |
8,767 |
6,936 |
$65K |
| 80050 |
General health panel |
817 |
810 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
13,817 |
10,112 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,318 |
1,944 |
$35K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,096 |
859 |
$34K |
| 80061 |
Lipid panel |
3,620 |
2,818 |
$26K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
359 |
143 |
$24K |
| 87631 |
|
189 |
174 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,235 |
1,881 |
$23K |
| 81001 |
|
5,136 |
4,087 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,389 |
1,917 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,431 |
1,880 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,519 |
2,788 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,033 |
863 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,960 |
5,039 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
424 |
335 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,558 |
2,868 |
$14K |
| 70450 |
Computed tomography, head or brain; without contrast material |
139 |
116 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
1,388 |
1,164 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
1,096 |
856 |
$12K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
393 |
333 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,417 |
1,819 |
$12K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
472 |
102 |
$12K |
| 87088 |
|
1,466 |
1,186 |
$9K |
| 80305 |
|
738 |
631 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,617 |
2,006 |
$8K |
| 83880 |
|
683 |
547 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,139 |
2,439 |
$7K |
| 81025 |
|
864 |
724 |
$6K |
| 82607 |
|
661 |
557 |
$6K |
| 84484 |
|
623 |
501 |
$5K |
| 84436 |
|
957 |
822 |
$4K |
| 86756 |
|
272 |
200 |
$4K |
| 80047 |
|
411 |
276 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
26 |
25 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
114 |
110 |
$2K |
| 80306 |
|
126 |
113 |
$2K |
| 81000 |
|
579 |
401 |
$2K |
| 83690 |
|
295 |
254 |
$2K |
| 90688 |
|
375 |
284 |
$2K |
| 92523 |
|
16 |
14 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,638 |
1,308 |
$1K |
| 87077 |
|
288 |
227 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
782 |
604 |
$1K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
1,225 |
831 |
$1K |
| 84439 |
|
210 |
149 |
$1K |
| 82150 |
|
160 |
144 |
$1K |
| 85610 |
|
539 |
273 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
358 |
306 |
$1K |
| 87186 |
|
268 |
212 |
$995.84 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
13 |
$935.16 |
| 71020 |
|
69 |
59 |
$901.00 |
| 83735 |
|
154 |
134 |
$867.21 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14 |
13 |
$831.99 |
| 86677 |
|
30 |
25 |
$393.68 |
| G0008 |
Administration of influenza virus vaccine |
219 |
171 |
$355.35 |
| 74018 |
|
14 |
12 |
$203.16 |
| 85379 |
|
40 |
29 |
$197.16 |
| 82043 |
|
67 |
52 |
$179.75 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
219 |
130 |
$94.02 |
| 36416 |
|
45 |
25 |
$52.78 |
| 85651 |
|
23 |
15 |
$30.42 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
60 |
56 |
$16.32 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
119 |
75 |
$1.47 |
| J2704 |
Injection, propofol, 10 mg |
26 |
26 |
$1.08 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
67 |
15 |
$0.00 |
| 82947 |
|
13 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
42 |
38 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
124 |
92 |
$0.00 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
500 |
465 |
$0.00 |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
23 |
13 |
$0.00 |